+

WO2008120263A3 - Antagonistes des récepteurs des prokinéticines, leurs dérivés et leurs utilisations - Google Patents

Antagonistes des récepteurs des prokinéticines, leurs dérivés et leurs utilisations Download PDF

Info

Publication number
WO2008120263A3
WO2008120263A3 PCT/IT2008/000216 IT2008000216W WO2008120263A3 WO 2008120263 A3 WO2008120263 A3 WO 2008120263A3 IT 2008000216 W IT2008000216 W IT 2008000216W WO 2008120263 A3 WO2008120263 A3 WO 2008120263A3
Authority
WO
WIPO (PCT)
Prior art keywords
prokineticins
derivatives
receptors antagonists
receptors
antagonists
Prior art date
Application number
PCT/IT2008/000216
Other languages
English (en)
Other versions
WO2008120263A2 (fr
Inventor
Lucia Negri
Donatella Barra
Pietro Malchiorri
Rossella Miele
Original Assignee
Univ Roma
Lucia Negri
Donatella Barra
Pietro Malchiorri
Rossella Miele
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Roma, Lucia Negri, Donatella Barra, Pietro Malchiorri, Rossella Miele filed Critical Univ Roma
Publication of WO2008120263A2 publication Critical patent/WO2008120263A2/fr
Publication of WO2008120263A3 publication Critical patent/WO2008120263A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des peptides dérivés de la protéine Bv8 ayant une activité antagoniste des récepteurs des prokinéticines PKR1 et PKR2, sans aucune activité hyperalgésique. L'invention concerne également leur utilisation dans le traitement de la douleur.
PCT/IT2008/000216 2007-04-03 2008-04-01 Antagonistes des récepteurs des prokinéticines, leurs dérivés et leurs utilisations WO2008120263A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2007A000182 2007-04-03
ITRM20070182 ITRM20070182A1 (it) 2007-04-03 2007-04-03 Antagonisti dei recettori delle prochineticine derivati di essi e loro uso

Publications (2)

Publication Number Publication Date
WO2008120263A2 WO2008120263A2 (fr) 2008-10-09
WO2008120263A3 true WO2008120263A3 (fr) 2008-12-18

Family

ID=39740059

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2008/000216 WO2008120263A2 (fr) 2007-04-03 2008-04-01 Antagonistes des récepteurs des prokinéticines, leurs dérivés et leurs utilisations

Country Status (2)

Country Link
IT (1) ITRM20070182A1 (fr)
WO (1) WO2008120263A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002782A1 (es) * 2007-09-21 2009-07-31 Genentech Inc Anticuerpo anti-bv8 neutralizante; composicion que lo comprende; y su uso para tratar tumores en humanos previamente tratados con un antagonista del factor de crecimiento endotelial vascular.
JP2013533878A (ja) * 2010-06-28 2013-08-29 ヤンセン ファーマシューティカ エヌ．ベー． 疼痛を処置するためのプロキネチシン１受容体拮抗薬
WO2012006004A1 (fr) * 2010-06-28 2012-01-12 Janssen Pharmaceutica Nv Antagonistes du récepteur-1 de la prokinéticine pour le traitement de la douleur
AU2013345018A1 (en) * 2012-11-13 2015-05-14 Regeneron Pharmaceuticals, Inc. Anti-prokineticin receptor (PROKR) antibodies and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087054A2 (fr) * 2003-03-25 2004-10-14 The Regents Of The University Of California Procedes de modulation de la secretion gastrique mettant en oeuvre des antagonistes du recepteur de la prokineticine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087054A2 (fr) * 2003-03-25 2004-10-14 The Regents Of The University Of California Procedes de modulation de la secretion gastrique mettant en oeuvre des antagonistes du recepteur de la prokineticine

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BERGER V ET AL: "Transport mechanisms of the large neutral amino acid L-phenylalanine in the human intestinal epithelial caco-2 cell line.", THE JOURNAL OF NUTRITION NOV 2000, vol. 130, no. 11, November 2000 (2000-11-01), pages 2780 - 2788, XP002497333, ISSN: 0022-3166 *
BULLOCK C M ET AL: "STRUCTURAL DETERMINANTS REQUIRED FOR THE BIOACTIVITIES OF PROKINETICINS AND IDENTIFICATION OF PROKINETICIN RECEPTOR ANTAGONISTS", MOLECULAR PHARMACOLOGY, BALTIMORE, MD, US, vol. 65, no. 3, 1 March 2004 (2004-03-01), pages 582 - 588, XP008028638, ISSN: 0026-895X *
LAI REN ET AL: "Two novel Bv8-like peptides from skin secretions of the toad Bombina maxima.", COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY. PART B, BIOCHEMISTRY & MOLECULAR BIOLOGY MAR 2003, vol. 134, no. 3, March 2003 (2003-03-01), pages 509 - 514, XP002497330, ISSN: 1096-4959 *
MOLLAY ET AL: "Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL, vol. 374, no. 2, 18 June 1999 (1999-06-18), pages 189 - 196, XP002123181, ISSN: 0014-2999 *
NEGRI L ET AL: "Nociceptive sensitization by the secretory protein Bv8", BRITISH JOURNAL OF PHARMACOLOGY, BASINGSTOKE, HANTS, vol. 137, no. 8, 1 December 2002 (2002-12-01), pages 1147 - 1154, XP002371986, ISSN: 0007-1188 *
NEGRI LUCIA ET AL: "Biological activities of Bv8 analogues.", BRITISH JOURNAL OF PHARMACOLOGY NOV 2005, vol. 146, no. 5, November 2005 (2005-11-01), pages 625 - 632, XP002497331, ISSN: 0007-1188 *
NEGRI LUCIA ET AL: "Modulators of pain: BV8 and prokineticins", CURRENT NEUROPHARMACOLOGY, vol. 4, no. 3, July 2006 (2006-07-01), pages 207 - 215, XP002497332, ISSN: 1570-159X *

Also Published As

Publication number Publication date
WO2008120263A2 (fr) 2008-10-09
ITRM20070182A1 (it) 2008-10-04

Similar Documents

Publication Publication Date Title
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
MA32568B1 (fr) Formulations pharmaceutiques contenant des ligands de recepteur de dopamine
FR2904316B1 (fr) Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
EA201170227A1 (ru) Имидазолкарбоксамиды
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
EA201390977A1 (ru) Комбинация агониста опиоидных рецепторов и антагониста опиоидных рецепторов для лечения болезни паркинсона
WO2010077882A3 (fr) Antagonistes des récepteurs d'acide lysophosphatidique
TW201129378A (en) Materials and methods for treating or preventing HER-3 associated diseases
BRPI0911984A2 (pt) sequências de aminoácidos direncionadas contra cxcr4 e outros compostos gpcrs compreendendo os mesmos
FR2910473B1 (fr) Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
WO2010085100A2 (fr) Nouveau domaine transmembranaire cellulaire et système de transduction intracellulaire contenant ce domaine
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
BRPI0814529A2 (pt) Derivados de 2-3-dihidrobenzo[1,4]dioxin-2-ilmetil como antagonistas alfa2c para o uso no tratamento de doenças do sistema nervoso periférico e central.
BRPI0911203A2 (pt) peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
EP4234698A3 (fr) Compositions et procédés d'utilisation d'anticorps thérapeutiques dirigés contre la protéine 6 liée à la lipoprotéine de basse densité (lrp6)
CL2014000849A1 (es) Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas.
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
SI2238110T1 (sl) Derivati 5,6-bisaril-2-piridin-karboksamida, njihova priprava in njihova terapevtska uporaba kot antagonisti receptorjev urotenzina II
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
WO2009047513A3 (fr) Composé, utilisation et procédé
EA201290808A1 (ru) Замещенные конденсированные производные имидазола, фармацевтические композиции и способы их применения
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751534

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08751534

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载